| Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer (NCT01302834) | Radiation Therapy Oncology Group | 2011-06-01 |
| Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer (NCT01330446) | M.D. Anderson Cancer Center | 2011-05-19 |
| A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery (NCT01355926) | Memorial Sloan Kettering Cancer Center | 2011-05-01 |
| Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer (NCT01359267) | University of Chicago | 2011-04-19 |
| TEST: Registry for Endoscopic Head and Neck Surgery (NCT01412749) | M.D. Anderson Cancer Center | 2011-04-01 |
| Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer (NCT01264328) | Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 2011-03-09 |
| Chemoradiotherapy With Elective Low Dose Nodal Radiation for Locally Advanced Head and Neck Cancer (NCT01372111) | Coastal Carolina Radiation Oncology | 2011-03-01 |
| Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy (NCT03887442) | Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 2011-02-16 |
| Monitoring of Bone Free Flaps With Microdialysis (NCT01879384) | Centre Hospitalier Universitaire, Amiens | 2011-02-01 |
| Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma (NCT01291095) | All India Institute of Medical Sciences | 2011-02-01 |
| Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors (NCT01310179) | PNP Therapeutics, Inc. | 2011-02-01 |
| Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer (NCT01161498) | BioVex Limited | 2011-02-01 |
| Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer (NCT00827164) | University of Alabama at Birmingham | 2011-01-01 |
| Pain: Screen and Treat (NCT01716780) | Royal Marsden NHS Foundation Trust | 2011-01-01 |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery (NCT01220583) | Radiation Therapy Oncology Group | 2011-01-01 |
| Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma (NCT02892786) | Institut de Cancérologie de Lorraine | 2010-12-08 |
| Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy (NCT01156142) | Alliance for Clinical Trials in Oncology | 2010-12-01 |
| Characterization of Head and Neck Malignant Tumors Using an Electronic Nose (NCT01816919) | Carmel Medical Center | 2010-11-01 |
| Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck Cancer (NCT01053546) | Wake Forest University Health Sciences | 2010-11-01 |
| Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment (NCT01184027) | University of Alberta | 2010-10-01 |
| A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy (NCT02130427) | Abramson Cancer Center at Penn Medicine | 2010-09-01 |
| Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer (NCT01084083) | Eastern Cooperative Oncology Group | 2010-08-11 |
| Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy (NCT01194635) | ECOG-ACRIN Cancer Research Group | 2010-08-05 |
| Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab (NCT01192750) | ECOG-ACRIN Cancer Research Group | 2010-08-05 |
| Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers (NCT01163487) | Daniel T. Chang | 2010-08-01 |
| Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) (NCT01183065) | Memorial Sloan Kettering Cancer Center | 2010-08-01 |
| Study of Chemo-Immunotherapy in Head and Neck Cancer Patients (NCT01149902) | University of Yamanashi | 2010-07-01 |
| Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer (NCT01173172) | Taipei Veterans General Hospital, Taiwan | 2010-07-01 |
| Goal Directed Fluid Therapy in Free Flap Reconstructive Surgery (NCT01129037) | University Health Network, Toronto | 2010-07-01 |
| A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors (NCT01171924) | Curis, Inc. | 2010-07-01 |
| Lapatinib and Cetuximab in Patients With Solid Tumors (NCT01184482) | Georgetown University | 2010-06-01 |
| Curcumin Biomarker Trial in Head and Neck Cancer (NCT01160302) | Louisiana State University Health Sciences Center Shreveport | 2010-06-01 |
| Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer (NCT01126216) | University of Erlangen-Nürnberg Medical School | 2010-06-01 |
| Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer (NCT00670397) | Roswell Park Cancer Institute | 2010-06-01 |
| A Study in Head and Neck Cancer (NCT01081041) | Eli Lilly and Company | 2010-06-01 |
| Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck (NCT01133678) | University of Chicago | 2010-05-04 |
| Transdermal Methylphenidate for Cancer-Related Fatigue (NCT01124500) | Memorial Sloan Kettering Cancer Center | 2010-05-01 |
| Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer (NCT01118065) | Leiden University Medical Center | 2010-05-01 |
| FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer (NCT00983697) | American College of Radiology Imaging Network | 2010-04-01 |
| Everolimus Versus Placebo in Head and Neck Cancer (NCT01111058) | University of Chicago | 2010-04-01 |
| RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer (NCT00956007) | Radiation Therapy Oncology Group | 2010-03-31 |
| Smoking Cessation Treatment for Head & Neck Cancer Patients (NCT01098955) | M.D. Anderson Cancer Center | 2010-03-24 |
| Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer (NCT01467115) | Drexel University College of Medicine | 2010-03-01 |
| Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN) (NCT01054625) | Genmab | 2010-03-01 |
| Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor (NCT01096381) | Vanderbilt-Ingram Cancer Center | 2010-03-01 |
| FNA Tumor Sampling for CD137 Modulation: A Pilot Study (NCT01114256) | Stanford University | 2010-03-01 |
| Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer (NCT01164176) | Yonsei University | 2010-03-01 |
| Phase II Study of Whole or Partial Parotid Sparing Intensity Modulated Radiotherapy in Patients With Head and Neck Cancers (NCT02068313) | Royal Marsden NHS Foundation Trust | 2010-03-01 |
| Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors (NCT01075399) | Siemens Molecular Imaging | 2010-02-01 |
| RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer (NCT01058408) | Dana-Farber Cancer Institute | 2010-02-01 |
| A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer (NCT01111942) | Southern Illinois University | 2010-02-01 |
| Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab (NCT01436617) | Centre Francois Baclesse | 2010-01-01 |
| Elective Mucosal Irradiation in Head-and-Neck Cancer of Unknown Primary (NCT02764216) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2010-01-01 |
| The Safety and Efficacy of the Harmonic Scalpel in Neck Dissection (NCT01488682) | Yonsei University | 2010-01-01 |
| Electromyographic Activity of Masseter Muscle During Deglutition in Total Laryngectomized Subjects (NCT01095289) | Universidade Federal de Pernambuco | 2010-01-01 |
| Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer. (NCT01124409) | All India Institute of Medical Sciences | 2009-12-01 |
| Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer (NCT01098669) | Vanderbilt University | 2009-12-01 |
| RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer (NCT01057277) | howard safran | 2009-12-01 |
| Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging System (NCT01030497) | M.D. Anderson Cancer Center | 2009-12-01 |
| Chlorhexidine Gel Therapy for Cariogenic Oral Microflora (NCT01036412) | M.D. Anderson Cancer Center | 2009-12-01 |
| Study of Pazopanib and Ixabepilone in Patients With Solid Tumors (NCT01012362) | Masonic Cancer Center, University of Minnesota | 2009-12-01 |
| Concomitant Chemoradiotherapy (CCRT) With Weekly Docetaxel and Cisplatin for Locally Advanced Head and Neck Cancer (NCT01126008) | Samsung Medical Center | 2009-11-16 |
| Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) (NCT01016769) | Memorial Sloan Kettering Cancer Center | 2009-11-01 |
| Randomised Study of Mucositis Prevention After Radiochemotherapy Treatment for Head and Neck Cancer (NCT01149642) | Institut du Cancer de Montpellier - Val d'Aurelle | 2009-11-01 |
| A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma (NCT01046266) | Hoffmann-La Roche | 2009-11-01 |
| RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN (NCT01009346) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-10-01 |
| Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors (NCT00908024) | Bristol-Myers Squibb | 2009-10-01 |
| Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer (NCT01011842) | Stanford University | 2009-10-01 |
| Functional Imaging of Tumor and Normal Tissue (NCT00933114) | Duke University | 2009-10-01 |
| Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery (NCT01333085) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2009-10-01 |
| Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck (NCT01044433) | Abramson Cancer Center at Penn Medicine | 2009-10-01 |
| Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC (NCT00997906) | National Cancer Centre, Singapore | 2009-09-15 |
| Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy (NCT01210872) | Centre Georges Francois Leclerc | 2009-09-01 |
| Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma (NCT00968435) | Memorial Sloan Kettering Cancer Center | 2009-08-01 |
| Induction Chemotherapy for Advanced Head and Neck Cancer (NCT00959387) | Barretos Cancer Hospital | 2009-08-01 |
| MRI in Finding Hypoxia in Patients Undergoing Chemo and Radiation for Head and Neck Cancer (NCT00896350) | University of Texas Southwestern Medical Center | 2009-07-08 |
| 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors (NCT00967577) | Weill Medical College of Cornell University | 2009-07-01 |
| A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC (NCT00882583) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-07-01 |
| Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma (NCT00942734) | M.D. Anderson Cancer Center | 2009-07-01 |
| Comprehensive Assessment of Head and Neck Cancer Survivors (NCT01222481) | Jay F. Piccirillo, MD | 2009-07-01 |
| Endoscopy Screening for Esophageal Cancer (NCT00927446) | Lotung Poh-Ai Hospital | 2009-06-01 |
| Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer (NCT01313390) | University College, London | 2009-06-01 |
| Acceptability of Less Harmful Alternatives to Cigarettes (NCT00957424) | Roswell Park Cancer Institute | 2009-06-01 |
| Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer (NCT00927147) | Boneca Corporation | 2009-06-01 |
| T-cell Based Immunotherapy for Head and Neck Cancer (NCT00937300) | Inge Marie Svane | 2009-06-01 |
| Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection (NCT00918281) | GE Healthcare | 2009-06-01 |
| Quality of Life in Patients Treated for Head and Neck Cancer (NCT00963586) | Maastricht Radiation Oncology | 2009-06-01 |
| Clinical Evaluation of the New Hypoxia Imaging Agent HX4 (NCT01213030) | Siemens Molecular Imaging | 2009-06-01 |
| The Physiological Response to Routine Head and Neck Cancer Surgery (NCT01032096) | Royal Marsden NHS Foundation Trust | 2009-05-01 |
| Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT00910117) | Fudan University | 2009-05-01 |
| Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced Mucositis (NCT00814359) | Juravinski Cancer Centre Foundation | 2009-05-01 |
| Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation (NCT00894101) | University of California, Irvine | 2009-05-01 |
| Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx (NCT00918762) | Barbara Ann Karmanos Cancer Institute | 2009-05-01 |
| Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer (NCT00891904) | Roswell Park Cancer Institute | 2009-04-01 |
| An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037 (NCT00884520) | Siemens Molecular Imaging | 2009-04-01 |
| Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer (NCT00881114) | Georgetown University | 2009-04-01 |
| Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC) (NCT00904345) | University of Michigan Rogel Cancer Center | 2009-04-01 |
| An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ... (NCT00924092) | National Cancer Institute (NCI) | 2009-03-13 |
| Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea (NCT01075828) | Merck KGaA, Darmstadt, Germany | 2009-03-01 |
| Resistance Training and Physical Functioning in Head and Neck Cancer Patients (NCT01332682) | University of Alabama at Birmingham | 2009-03-01 |